Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch et al

Detalles Bibliográficos
Autores principales: Chheda, Zinal S, Mueller, Sabine, Hegde, Bindu, Yamamichi, Akane, Butterfield, Lisa H, Okada, Hideho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032395/
https://www.ncbi.nlm.nih.gov/pubmed/36944450
http://dx.doi.org/10.1136/jitc-2022-006617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032395/
https://www.ncbi.nlm.nih.gov/pubmed/36944450
http://dx.doi.org/10.1136/jitc-2022-006617

Ejemplares similares